Nonsteroidal Anti-inflammatory Drug and Aspirin-induced Peptic Ulcer Disease
Despite decreasing Helicobacter pylori prevalence, the prevalence of peptic ulcer disease is increasing in the aged population, mainly due to increasing use of NSAIDs to manage pain and inflammation. In addition, low dose aspirin is employed as an anti-coagulant for those who have suffered or are at...
Main Authors: | Young Kwang Shim, Nayoung Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Jin Publishing & Printing Co.
2016-06-01
|
Series: | The Korean Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2016.67.6.300 |
Similar Items
-
The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis
by: Ki-Nam Shim, et al.
Published: (2019-09-01) -
Risk of Peptic Ulcer Bleeding Associated with Infection, Nonsteroidal Anti-inflammatory Drugs, and Low-dose Aspirin Therapy in Peptic Ulcer Disease: A Case-control Study
by: Seung In Seo, et al.
Published: (2019-03-01) -
Helicobacter pylori Eradication in Drug-related Peptic Ulcer
by: Moon Kyung Joo
Published: (2020-11-01) -
The Role of Helicobacter pylori Infection in Drug-induced Peptic Ulcer
by: Jin Sung Koh, et al.
Published: (2018-06-01) -
Prevention of Non-steroidal Anti-inflammatory Drug-induced Peptic Ulcers
by: Seong Jun Chu, et al.
Published: (2020-11-01)